Location History:
- Ann Arbor, MI (US) (2013)
- Heifei, CN (2016)
Company Filing History:
1 out of 3,397 
1 out of 832,966 Years Active: 2013-2016
Title: Suling Liu: Innovator in Cancer Stem Cell Research
Introduction
Suling Liu is a prominent inventor based in Hefei, China, known for his significant contributions to cancer research. He holds 2 patents that focus on innovative methods for diagnosing and treating cancer stem cells. His work has the potential to revolutionize cancer therapies and improve patient outcomes.
Latest Patents
Liu's latest patents include a method for reducing the number of EMT and MET type breast cancer stem cells. This invention discloses compositions, kits, and methods for therapeutic screening, diagnostics, and cancer treatment based on the identification or use of different states of cancer stem cells. The methods involve treating a subject with therapeutics that target both EMT and MET cancer stem cells. Additionally, the invention highlights the use of specific markers to distinguish between different cancer stem cell states, such as CD44+CD24− and ALDH+. Another notable patent introduces ALDH1 as a novel cancer stem cell marker, which is useful for diagnosing and characterizing solid tumor stem cells.
Career Highlights
Throughout his career, Suling Liu has worked at various institutions, including the University of Michigan. His research has focused on understanding the complexities of cancer stem cells and developing targeted therapies to combat cancer more effectively.
Collaborations
Liu has collaborated with notable researchers in the field, including Max S. Wicha and Gabriela Dontu. Their combined expertise has contributed to advancing the understanding of cancer stem cells and their role in tumor progression.
Conclusion
Suling Liu's innovative work in cancer stem cell research exemplifies the potential of targeted therapies in oncology. His patents and collaborations highlight the importance of continued research in this critical area of medicine.